(Q43290386)

English

Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial

scientific article published on 18 August 2009

Statements

Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial (English)
18 August 2009
2328-2336

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit